These data, together with the results of the microscopic analysis of sym40-1 nodules treated with 0.1 mM GSH, where a decrease in the size of hypertrophied infection droplets was observed, as well as the fact that the highest hGSH content was detected in sym33-3 nodules, where infection threads rarely formed infection droplets, suggest that hGSH may play a role in infection droplet formation
10.1007/s00203-017-1459-x Summary Keywords gut microbiota, gastrointestinal diseases, cancer, therapy, dysbiosis Citation Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman SU, Suleman, Ullah I, Hassan IU, Tian Y and Li K (2025) Gut microbiota therapy in gastrointestinal diseases
8 weeks (1 vial): 3 mL 1 10 mL bottle 12 weeks (2 vials): 6 mL 1 10 mL bottle 16 weeks (3 vials): 9 mL 1 10 mL bottle Alcohol Swabs: One for the vial stopper + one for the injection site each week
Only change if side effects or clear issues
A.VasquezK.WaltenbaughC
doi: 10.1016/j.fertnstert.2012.11.045
